ACETAMINOPHEN, IBUPROFEN

ACETAMINOPHEN, IBUPROFEN was reported 370 times

ACETAMINOPHEN, IBUPROFEN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PROCEDURAL HEADACHE 2 0.0049
1 BACTERIA URINE IDENTIFIED 1 0.0047
2 INCREASED NEED FOR SLEEP 1 0.0043
3 ANTICOAGULANT THERAPY 1 0.0035
4 WHITE BLOOD CELL COUNT 1 0.0034
5 NITRITE URINE PRESENT 1 0.0023
6 OESOPHAGEAL INFECTION 1 0.0022
7 ALLERGY TO ARTHROPOD STING 1 0.0022
8 POSTNASAL DRIP 1 0.0018
9 LYMPHATIC DISORDER 1 0.0017
10 DIAPHRAGMATIC PARALYSIS 1 0.0017
11 BLOOD BILIRUBIN DECREASED 1 0.0016
12 CORNEAL PERFORATION 1 0.0016
13 INTESTINAL FUNCTIONAL DISORDER 1 0.0016
14 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
15 ARTHROSCOPY 1 0.0015
16 DYSBIOSIS 1 0.0012
17 HEPATIC CANCER METASTATIC 1 0.0012
18 HEART TRANSPLANT 1 0.0011
19 BONE CONTUSION 1 0.0011
20 PRODUCT AFTER TASTE 1 0.0010
21 PROSTATE INFECTION 1 0.0010
22 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 30 0.0010
23 OROPHARYNGEAL SWELLING 1 0.0010
24 DRUG EFFECT LESS THAN EXPECTED 15 0.0010
25 BLOODY DISCHARGE 1 0.0009
26 HAEMATOMA MUSCLE 1 0.0008
27 CHRONIC RESPIRATORY FAILURE 1 0.0008
28 FRACTURED SACRUM 1 0.0008
29 OBLITERATIVE BRONCHIOLITIS 1 0.0008
30 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
31 MENINGITIS VIRAL 1 0.0007
32 HYPOSMIA 1 0.0007
33 HEPATORENAL SYNDROME 1 0.0006
34 SKIN HYPOPIGMENTATION 1 0.0006
35 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
36 PNEUMOMEDIASTINUM 1 0.0006
37 LYMPH NODE PAIN 1 0.0005
38 BLADDER SPASM 1 0.0005
39 PANCREATIC CYST 1 0.0005
40 THERAPEUTIC PRODUCT EFFECT VARIABLE 2 0.0005
41 FAECES HARD 2 0.0005
42 HYPOGEUSIA 1 0.0005
43 VASCULAR OCCLUSION 1 0.0005
44 EAR SWELLING 1 0.0005
45 RHEUMATIC FEVER 2 0.0004
46 INFECTIOUS MONONUCLEOSIS 1 0.0004
47 URINARY TRACT DISORDER 2 0.0004
48 VASCULAR DEVICE INFECTION 2 0.0004
49 INFUSION SITE INFECTION 1 0.0004
50 PATELLA FRACTURE 1 0.0004
51 SLOW SPEECH 1 0.0004
52 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
53 CARTILAGE INJURY 1 0.0004
54 HAEMORRHAGE URINARY TRACT 1 0.0004
55 ULCERATIVE KERATITIS 1 0.0004
56 PANCREATIC CARCINOMA METASTATIC 1 0.0004
57 KERATITIS 1 0.0003
58 NON-CARDIAC CHEST PAIN 1 0.0003
59 OTITIS MEDIA 1 0.0003
60 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
61 DEFAECATION URGENCY 2 0.0003
62 LUNG TRANSPLANT 1 0.0003
63 SEBORRHOEA 1 0.0003
64 RECTAL DISCHARGE 1 0.0003
65 CATHETER SITE INFECTION 1 0.0003
66 HALLUCINATIONS, MIXED 1 0.0002
67 SLEEP TERROR 1 0.0002
68 INTERVERTEBRAL DISC DISORDER 1 0.0002
69 TEARFULNESS 1 0.0002
70 IMMOBILE 1 0.0002
71 MENINGITIS ASEPTIC 1 0.0002
72 IRON DEFICIENCY 1 0.0002
73 PAPILLOEDEMA 1 0.0002
74 SUSPECTED OFF LABEL USE 1 0.0002
75 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
76 ROSACEA 1 0.0002
77 DIABETIC NEUROPATHY 1 0.0002
78 PROTEIN URINE PRESENT 1 0.0002
79 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
80 PATHOLOGICAL FRACTURE 1 0.0002
81 BODY TEMPERATURE INCREASED 4 0.0002
82 TRISMUS 1 0.0002
83 FAILURE TO THRIVE 1 0.0002
84 AUTISM SPECTRUM DISORDER 1 0.0002
85 STREPTOCOCCAL INFECTION 1 0.0002
86 UNDERDOSE 13 0.0002
87 PERONEAL NERVE PALSY 1 0.0002
88 VISUAL DISTURBANCE 1 0.0002
89 URINE ODOUR ABNORMAL 1 0.0002
90 PLEURISY 1 0.0002
91 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
92 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
93 HIATUS HERNIA 2 0.0002
94 PRODUCT FORMULATION ISSUE 1 0.0002
95 CORONAVIRUS INFECTION 1 0.0002
96 SKIN MASS 1 0.0001
97 ULCER HAEMORRHAGE 1 0.0001
98 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
99 ENCEPHALITIS 1 0.0001
100 METASTASIS 1 0.0001
101 INJECTION SITE HAEMATOMA 2 0.0001
102 FEELING DRUNK 1 0.0001
103 GENERAL SYMPTOM 1 0.0001
104 PELVIC FRACTURE 1 0.0001
105 DRUG SCREEN POSITIVE 1 0.0001
106 SPINAL COMPRESSION FRACTURE 1 0.0001
107 PSEUDOMONAS INFECTION 1 0.0001
108 CARDIAC MURMUR 1 0.0001
109 PYELONEPHRITIS 1 0.0001
110 GRIP STRENGTH DECREASED 1 0.0001
111 OROPHARYNGEAL DISCOMFORT 1 0.0001
112 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
113 PHOTOPHOBIA 2 0.0001
114 SPUTUM DISCOLOURED 1 0.0001
115 BLOOD URINE PRESENT 2 0.0001
116 ATELECTASIS 1 0.0001
117 SINUS BRADYCARDIA 1 0.0001
118 AUTOIMMUNE DISORDER 1 0.0001
119 SINUS DISORDER 2 0.0001
120 BLADDER DISORDER 1 0.0001
121 INJECTION SITE DISCOMFORT 1 0.0001
122 SUDDEN DEATH 1 0.0001
123 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
124 BACK INJURY 1 0.0001
125 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
126 STEVENS-JOHNSON SYNDROME 2 0.0001
127 OCULAR DISCOMFORT 1 0.0001
128 NEOPLASM 1 0.0001
129 SPLENOMEGALY 1 0.0001
130 BLOOD IRON DECREASED 1 0.0001
131 DISEASE RECURRENCE 4 0.0001
132 PRODUCT ADHESION ISSUE 3 0.0001
133 MACULAR DEGENERATION 1 0.0001
134 ACCIDENT 1 0.0001
135 MOBILITY DECREASED 6 0.0001
136 NOCTURIA 1 0.0001
137 LIVER INJURY 2 0.0001
138 MUSCLE SPASTICITY 1 0.0001
139 SPINAL OPERATION 1 0.0001
140 BRAIN OEDEMA 1 0.0001
141 INTRAOCULAR PRESSURE INCREASED 1 0.0001
142 ROTATOR CUFF SYNDROME 1 0.0001
143 QUALITY OF LIFE DECREASED 1 0.0001
144 EXTRA DOSE ADMINISTERED 3 0.0001
145 UVEITIS 1 0.0001
146 IMPAIRED GASTRIC EMPTYING 1 0.0001
147 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
148 DEMENTIA 2 0.0001
149 PARALYSIS 1 0.0001
150 ANOSMIA 1 0.0001
151 BLOOD COUNT ABNORMAL 1 0.0001
152 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
153 PHARYNGEAL OEDEMA 1 0.0001
154 MUSCULOSKELETAL CHEST PAIN 1 0.0001
155 DELUSION 1 0.0001
156 THERAPY PARTIAL RESPONDER 1 0.0001
157 PRODUCT USE COMPLAINT 1 0.0001
158 PNEUMOTHORAX 1 0.0001
159 CYSTITIS 2 0.0001
160 SENSORY DISTURBANCE 1 0.0001
161 MOVEMENT DISORDER 2 0.0001
162 HIP FRACTURE 2 0.0001
163 MANIA 1 0.0001
164 EXPIRED PRODUCT ADMINISTERED 2 0.0001
165 PERICARDITIS 1 0.0001
166 SCAR 1 0.0001
167 GASTRIC DISORDER 2 0.0001
168 PARANOIA 1 0.0001
169 MULTI-ORGAN FAILURE 1 0.0001
170 NIGHTMARE 2 0.0001
171 DEVICE DEFECTIVE 1 0.0001
172 MUSCULOSKELETAL STIFFNESS 5 0.0001
173 METASTASES TO LIVER 1 0.0001
174 SLEEP DISORDER 4 0.0001
175 GOUT 1 0.0001
176 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
177 GASTROENTERITIS VIRAL 1 0.0001
178 CONSTIPATION 12 0.0001
179 RESTLESS LEGS SYNDROME 1 0.0001
180 BONE DISORDER 1 0.0001
181 DYSURIA 2 0.0001
182 THINKING ABNORMAL 1 0.0001
183 INTESTINAL OBSTRUCTION 2 0.0001
184 FOOT FRACTURE 1 0.0001
185 MUSCULOSKELETAL DISORDER 1 0.0001
186 SLEEP APNOEA SYNDROME 1 0.0001
187 INCREASED APPETITE 1 0.0001
188 EAR PAIN 1 0.0001
189 SURGERY 3 0.0001
190 OVERDOSE 11 0.0001
191 KIDNEY INFECTION 1 0.0001
192 DISORIENTATION 2 0.0001
193 INTENTIONAL SELF-INJURY 1 0.0000
194 FEEDING DISORDER 1 0.0000
195 TASTE DISORDER 1 0.0000
196 RIB FRACTURE 1 0.0000
197 PULMONARY HYPERTENSION 1 0.0000
198 POLLAKIURIA 2 0.0000
199 KNEE ARTHROPLASTY 1 0.0000
200 HALLUCINATION, VISUAL 1 0.0000
201 BALANCE DISORDER 4 0.0000
202 FAECES DISCOLOURED 1 0.0000
203 DRUG INEFFECTIVE 60 0.0000
204 TOOTH DISORDER 1 0.0000
205 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
206 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
207 PRODUCT AVAILABILITY ISSUE 1 0.0000
208 HYPERSENSITIVITY 8 0.0000
209 RENAL DISORDER 2 0.0000
210 ARRHYTHMIA 2 0.0000
211 GAIT DISTURBANCE 8 0.0000
212 LOCALISED INFECTION 1 0.0000
213 NEURALGIA 1 0.0000
214 CEREBRAL INFARCTION 1 0.0000
215 ABASIA 1 0.0000
216 AGEUSIA 1 0.0000
217 DRY EYE 2 0.0000
218 COVID-19 7 0.0000
219 HALLUCINATION 3 0.0000
220 HOT FLUSH 3 0.0000
221 SOMNOLENCE 8 0.0000
222 INCORRECT DOSE ADMINISTERED 9 0.0000
223 HYPOPHAGIA 1 0.0000
224 ANAPHYLACTIC SHOCK 1 0.0000
225 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
226 SEDATION 1 0.0000
227 ARTHRITIS 3 0.0000
228 JOINT STIFFNESS 1 0.0000
229 GASTRITIS 1 0.0000
230 CARDIAC FAILURE 3 0.0000
231 FEAR 1 0.0000
232 JAUNDICE 1 0.0000
233 PAIN OF SKIN 1 0.0000
234 RESPIRATORY DISTRESS 1 0.0000
235 ABNORMAL DREAMS 1 0.0000
236 HAEMOPTYSIS 1 0.0000
237 PAIN IN JAW 1 0.0000
238 FLATULENCE 2 0.0000
239 URINARY TRACT INFECTION 6 0.0000
240 INTENTIONAL DOSE OMISSION 1 0.0000
241 RED BLOOD CELL COUNT DECREASED 1 0.0000
242 HERPES ZOSTER 2 0.0000
243 PRODUCT SUBSTITUTION ISSUE 2 0.0000
244 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
245 ASCITES 1 0.0000
246 URINARY INCONTINENCE 1 0.0000
247 RESPIRATORY DISORDER 1 0.0000
248 BLOOD POTASSIUM DECREASED 1 0.0000
249 HEPATIC FAILURE 1 0.0000
250 LACRIMATION INCREASED 1 0.0000
251 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
252 DISCOMFORT 2 0.0000
253 OROPHARYNGEAL PAIN 3 0.0000
254 GYNAECOMASTIA 1 0.0000
255 MOOD SWINGS 1 0.0000
256 RHINORRHOEA 2 0.0000
257 SWELLING FACE 2 0.0000
258 DYSPEPSIA 3 0.0000
259 IMPAIRED HEALING 1 0.0000
260 EYE DISORDER 1 0.0000
261 HEART RATE INCREASED 3 0.0000
262 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
263 BACK PAIN 7 0.0000
264 VIRAL INFECTION 1 0.0000
265 LIP SWELLING 1 0.0000
266 MALAISE 13 0.0000
267 PRODUCT QUALITY ISSUE 4 0.0000
268 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
269 ACCIDENTAL OVERDOSE 1 0.0000
270 PRODUCT DOSE OMISSION ISSUE 8 0.0000
271 BRONCHITIS 2 0.0000
272 DYSGEUSIA 2 0.0000
273 DYSPNOEA EXERTIONAL 1 0.0000
274 MUSCULAR WEAKNESS 3 0.0000
275 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
276 PLASMA CELL MYELOMA 1 0.0000
277 PARAESTHESIA 4 0.0000
278 ABNORMAL BEHAVIOUR 1 0.0000
279 INJECTION SITE BRUISING 2 0.0000
280 COUGH 7 0.0000
281 BLINDNESS 1 0.0000
282 OSTEOPOROSIS 1 0.0000
283 DRUG ABUSE 2 0.0000
284 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
285 CARDIO-RESPIRATORY ARREST 1 0.0000
286 ABDOMINAL DISCOMFORT 4 0.0000
287 SKIN EXFOLIATION 2 0.0000
288 OSTEOARTHRITIS 1 0.0000
289 MYALGIA 4 0.0000
290 RECTAL HAEMORRHAGE 1 0.0000
291 HYPOACUSIS 1 0.0000
292 MENTAL DISORDER 1 0.0000
293 ANGIOEDEMA 1 0.0000
294 LIVER DISORDER 1 0.0000
295 THROAT IRRITATION 1 0.0000
296 MEMORY IMPAIRMENT 3 0.0000
297 SKIN IRRITATION 1 0.0000
298 NEPHROLITHIASIS 1 0.0000
299 SKIN DISCOLOURATION 1 0.0000
300 DIARRHOEA 14 0.0000
301 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
302 BLOOD CHOLESTEROL INCREASED 1 0.0000
303 COGNITIVE DISORDER 1 0.0000
304 NEUROPATHY PERIPHERAL 2 0.0000
305 RENAL CANCER 1 0.0000
306 MIGRAINE 2 0.0000
307 PRODUCTIVE COUGH 1 0.0000
308 MULTIPLE SCLEROSIS 1 0.0000
309 BLOOD GLUCOSE DECREASED 1 0.0000
310 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
311 INFECTION 3 0.0000
312 LUNG DISORDER 1 0.0000
313 CELLULITIS 1 0.0000
314 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
315 CONDITION AGGRAVATED 6 0.0000
316 SINUSITIS 2 0.0000
317 THERAPY CESSATION 1 0.0000
318 INFLAMMATION 1 0.0000
319 SPEECH DISORDER 1 0.0000
320 INSOMNIA 5 0.0000
321 DRUG DEPENDENCE 3 0.0000
322 DRUG EFFECT DECREASED 1 0.0000
323 PNEUMONIA 6 0.0000
324 RASH PRURITIC 1 0.0000
325 OFF LABEL USE 16 0.0000
326 HAEMATOCHEZIA 1 0.0000
327 MEDICATION ERROR 1 0.0000
328 WEIGHT DECREASED 5 0.0000
329 DEPRESSION 4 0.0000
330 HEADACHE 11 0.0000
331 ABDOMINAL PAIN 4 0.0000
332 DYSPHONIA 1 0.0000
333 PALPITATIONS 2 0.0000
334 BONE PAIN 1 0.0000
335 CHILLS 2 0.0000
336 NASAL CONGESTION 1 0.0000
337 BLADDER CANCER 1 0.0000
338 PAIN IN EXTREMITY 5 0.0000
339 ARTHRALGIA 7 0.0000
340 FATIGUE 13 0.0000
341 FEELING ABNORMAL 4 0.0000
342 PLEURAL EFFUSION 1 0.0000
343 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
344 PAIN 10 0.0000
345 CHEST PAIN 3 0.0000
346 INTENTIONAL OVERDOSE 1 0.0000
347 HYPERHIDROSIS 2 0.0000
348 AMNESIA 1 0.0000
349 ALOPECIA 3 0.0000
350 INFUSION RELATED REACTION 1 0.0000
351 FALL 5 0.0000
352 DEHYDRATION 2 0.0000
353 VOMITING 7 0.0000
354 VISION BLURRED 2 0.0000
355 BURNING SENSATION 1 0.0000
356 DEVICE MALFUNCTION 1 0.0000
357 HYPERTENSION 3 0.0000
358 THERAPY INTERRUPTED 1 0.0000
359 SKIN BURNING SENSATION 1 0.0000
360 EPISTAXIS 1 0.0000
361 ASTHENIA 5 0.0000
362 ACNE 1 0.0000
363 HOSPITALISATION 2 0.0000
364 PRURITUS 5 0.0000
365 DECREASED APPETITE 3 0.0000
366 PROSTATE CANCER 1 0.0000
367 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
368 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
369 INFLUENZA LIKE ILLNESS 1 0.0000
370 CARDIAC ARREST 1 0.0000
371 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
372 TREMOR 2 0.0000
373 URTICARIA 2 0.0000
374 MYOCARDIAL INFARCTION 2 0.0000
375 INTENTIONAL PRODUCT MISUSE 1 0.0000
376 NAUSEA 9 0.0000
377 GASTROINTESTINAL DISORDER 1 0.0000
378 ADVERSE EVENT 1 0.0000
379 CARDIAC DISORDER 1 0.0000
380 DYSPNOEA 6 0.0000
381 ANAEMIA 2 0.0000
382 ATRIAL FIBRILLATION 1 0.0000
383 DIZZINESS 5 0.0000
384 HYPOTENSION 2 0.0000
385 HAEMOGLOBIN DECREASED 1 0.0000
386 ABDOMINAL PAIN UPPER 2 0.0000
387 HAEMORRHAGE 1 0.0000
388 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
389 RASH 4 0.0000
390 SEPSIS 1 0.0000
391 THROMBOCYTOPENIA 1 0.0000
392 WEIGHT INCREASED 2 0.0000
393 RHEUMATOID ARTHRITIS 1 0.0000
394 PYREXIA 3 0.0000
395 SEIZURE 1 0.0000
396 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
397 VISUAL IMPAIRMENT 1 0.0000
398 LOSS OF CONSCIOUSNESS 1 0.0000
399 ANXIETY 2 0.0000
400 DEATH 6 0.0000
401 HYPOAESTHESIA 1 0.0000
402 ACUTE KIDNEY INJURY 1 0.0000
403 DRUG INTERACTION 1 0.0000
404 CONFUSIONAL STATE 1 0.0000
405 DRUG DOSE OMISSION 1 0.0000
406 TOXICITY TO VARIOUS AGENTS 1 0.0000
407 NO ADVERSE EVENT 1 0.0000
408 MUSCLE SPASMS 1 0.0000
409 NASOPHARYNGITIS 1 0.0000
410 BLOOD GLUCOSE INCREASED 1 0.0000
411 ERYTHEMA 1 0.0000
412 INJECTION SITE PAIN 1 0.0000